The apolipoprotein E4 allele is not associated with an abnormal lipid profile in a Native American population following its traditional lifestyle

Atherosclerosis

Volumn 142, Issue 2, 1999, Pages 409-414

  Aguilar, Carlos A ^a   Talavera, Guadalupe ^c   Ordovas, Jose M ^b   Barriguete, Jorge A ^a   Guillén, Luz E ^a   Leco, Marta E ^c   Pedro Botet, Juan ^b   Gonzalez Barranco, Jorge ^a   Gómez Pérez, Francisco J ^a   Rull, Juan A ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b U S DEPARTMENT OF AGRICULTURE   (United States)

^c Clínica de Diabetes Hospital General IMSS Michoacan   (Mexico)

Author keywords

Apolipoprotein E; Lipoprotein (a); Native Americans

Indexed keywords

APOLIPOPROTEIN E4; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALLELE; ARTICLE; CORONARY RISK; DIET; ENVIRONMENTAL FACTOR; FEMALE; GENE LOCUS; GENETIC VARIABILITY; HUMAN; HYPERCHOLESTEROLEMIA; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEXICO; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0032913092     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00251-2     Document Type: Article

References (30)

1. März W, Baumstark M.W, Scharnagl H, Ruzicka V, Buxbaum S, Herwig J, Pohl T, Russ A, Schaaf L, Berg A, Böhles H.J, Usadel K.H, Grob W Accumulation of 'small dense' low density lipoprotein (LDL) in homozugous patient with familial defective apolipoprotein B-100 results from heterogeneous interaction of LDL subfractions with the LDL receptor. J Clin Invest. 92:1993;2922-2933.
2. Hallman D.M, Boerwinkle E, Saha N, Sandholzer C, Menzel H.J, Csázár, Utermann G The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet. 49:1991;338-349.
3. Mahley R.W Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240:1988;622-630.
4. Dallongeville J, Lussier-Cacan S, Davignon J Modulation of plasma triglycerides levels by apoE phenotype: a meta-analysis. J Lipid Res. 33:1992;447-454.
5. Eichner J.E, Kuller L.H, Orchard T.J et al. Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol. 71:1993;160-165.
6. deAndrade M, Thandi I, Brown S et al. Relationship of apolipoprotein E polymorphism with carotid artery atherosclerosis. Am J Hum Genet. 56:1995;1379-1390.
7. Bredie S.J, Vogelaar J.M, Demacker P.N et al. Apolipoprotein E polimorphism influence lipid phenotypic expression, but not the low density lipoprotein subfraction distribution in familial combined hyperlipidemia. Atherosclerosis. 126:1996;313-324.
8. Ordovas J.M, Lopez M.J, Perez F et al. Effects of apolipoprotein E and A-IV phenotypes on low density lipoprotein response to HMG CoA reductase inhibitor therapy. Atherosclerosis. 113:1995;157-166.
9. Lopez M.J, Ordovas J.M, Mata P, Lichtenstein A.H, Clevidence B, Judd J.T, Schaefer E.J Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density cholesterol. J Lipid Res. 35:1994;1965-1975.
10. Dreon D.M, Fernstrom H.A, Miller B, Krauss R.M Apolipoprotein E isoform phenotype and LDL subclass response to a reduced fat diet. Arterioscler Thromb Vasc Biol. 15:1995;105-111.
11. Ordovas J.M, Lopez M.J, Mata P Gene-diet interaction in determining plasma lipd response to dietary intervention. Atherosclerosis. 118:1995;11-27.
12. Werle E, Fiehn W, Hasslacher C et al. Apolipoprotein E polymorphism and renal function in german type 1 and type 2 diabetic patients. Diabetes Care. 21:1998;994-998.
13. Davignon J, Gregg R.F, Sing C.F Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 8:1988;1-21.
14. Ehnholm C, Lukka M, Kuusi T et al. Apolipoprotein E polymorphism in the Finninsh popúlation: gene frequencies and relation to lipoprotein concentration. J Lipid Res. 27:1986;227-235.
15. Braeckman L, De Bacquier D, Rosseneu M et al. Apolipoprotein E polimorphism in middle aged Belgian men:phenotype distribution and relation to serum lipids and lipoproteins. Atherosclerosis. 120:1996;67-73.
16. Nikkila M et al. Women have a larger and less atherogenic low density lipoprotein particle size than men. Atherosclerosis. 119:1996;181-190.
17. Boemi M, Sirolla C, Amadio L et al. Apolipoprotein E polymorphism as a risk factor for vascular disease in diabetic patients. Diabetes Care. 18:1995;504-508.
18. Valdez R, Stern M, Howard B et al. Apolipoprotein E Polymorphism and Insulin Levels in a Biethnic Population. Diabetes Care. 18:1995;992-1000.
19. Rull J.A, Rios J.M, Gomez F.J, Olaiz G, Tapia R, Sepulveda J The impact of diabetes mellitus on public health in Mexico. Schwartz C.J, Born G New Horizons in Diabetes Mellitus & Cardiovascular Disease. 1995;64-74 Current Science.
20. Hixson J.E, Vernier D.T Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 31:1990;545-548.
21. Secretaria de Salud de México. Encuesta Nacional de Enfermedades Crónicas. Publicación de la Secretaria de Salud 1994. México City.
22. Savolainen M.J, Rantal M, Kervinen K et al. Magnitude of dietary effects on plasma cholesterol concentrations:role of sex and apolipoprotein E phenotype. Atherosclerosis. 86:1991;145.
23. Campos H, D'Agostino M, Ordovas J.M Effects of saturated fat intake and apolipoprotein E polymorphism on the plasma lipoprotein profile in Costa Rica. Atherosclerosis. 134(1,2):1997;76.
24. Boer J, Ehnholm C, Menzel H, Havekes L, Rosseneu M, St J.O'Reilly D et al. Interaction between lifestyle-related factors and the apo E polymorphism on plasma lipids and apolipoproteins. the EARS Study. Arterioscler Thromb Vasc Biol. 17:1997;1675-1681.
25. Wilson P.F, Schaefer E, Larson M, Ordovas J.M Apolipoprotein E alleles and risk of coronary disease. Arterioscler Thromb Vasc Biol. 16:1996;1250-1255.
26. Kataoka S, Robbins D, Cowan L et al. Apolipoprotein E polymorphism in American Indians and Its Relation to Plasma Lipoproteins and Diabetes. The Strong Heart Study. Arterioscler Thromb Vasc Biol. 16:1996;918-925.
27. Berger G.M, Naidoo J, Gounden N et al. Marked hyperinsulinemia in postmenopausal, healthy Indian (Asian) women. Diabetic med. 12:1995;788-795.
28. Gaw A, Boerwinkle E, Cohen J, Hobbs H Comparative analysis of the apo (a) gene, apo (a) glycoprotein, and plasma concentration of Lp(a) in three ethnic groups. J Clin Invest. 93:1994;2526-2534.
29. Casanueva E, Calvo V, Cid C, Ulloa X, Sepulveda J, Cristian M, Chiang M, Influencia de la Etnia sobre los niveles de Lp(a) y sus isoformas. Abstract presented at the Third meeting of the Sociedad Latinoamericana de Ateroesclerosis, 1995.
30. Klezovitch O, Scanu A Heterogeneity of lipoprotein (a): growing complexities. Curr Opinion Lipidol. 6:1995;223-228.